ZIKV IgM特异性诊断试验结果与先天性疾病新生儿中和抗体检测高度相关
该研究检测了42对微脑畸形母亲和新生儿的血液及30例新生儿脑脊液,发现新生儿ZIKV IgM血清阳性率90.5%、脑脊液100%,且所有IgM阳性结果均被中和抗体检测确认。结论认为新生儿血清ZIKV IgM可确诊先天性ZIKV感染,脑脊液IgM可确诊神经系统感染,建议对疑似先天性ZIKV感染新生儿检测IgM,不确定时行PRNT。
要点
- 新生儿血清ZIKV IgM阳性可确诊先天性ZIKV感染。
- 新生儿脑脊液ZIKV IgM阳性可确诊神经系统ZIKV感染。
- 所有IgM阳性结果均经中和抗体检测确认,不确定病例应行PRNT。
核心结论
- 新生儿血清ZIKV IgM检测可确诊先天性ZIKV感染,脑脊液IgM检测可确诊神经系统感染。
- 建议对疑似先天性ZIKV感染新生儿检测ZIKV IgM,不确定病例行PRNT。
研究设计与样本
- 研究纳入42对微脑畸形母亲和新生儿,并采集30例新生儿脑脊液标本。
- 采用分子 assay 检测ZIKV、登革病毒和基孔肯雅病毒,采用IgM ELISA和PRNT检测ZIKV和登革病毒。
- 未评估无微脑畸形的对照新生儿。
主要发现
- 新生儿中42例ZIKV IgM均阳性:血清38/42(90.5%)阳性,脑脊液30/30(100%)阳性。
- 所有新生儿ZIKV IgM阳性结果均通过中和抗体检测确认。
- 原发ZIKV感染母亲/新生儿对仅ZIKV有中和抗体;继发于其他黄病毒感染的母亲/新生儿对ZIKV有高中和抗体滴度。
临床怎么用
- 对疑似先天性ZIKV感染新生儿检测血清和脑脊液ZIKV IgM。
- IgM结果不确定时进行PRNT以确认。
局限性
- 未纳入无微脑畸形的对照新生儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Usually, immunoglobulin M (IgM) serologic analysis is not sufficiently specific to confirm Zika virus (ZIKV) infection. However, since IgM does not cross the placenta, it may be a good marker of infection in neonates. METHODS: We tested blood from 42 mothers and neonates with microcephaly and collected cerebrospinal fluid (CSF) specimens from 30 neonates. Molecular assays were performed for detection of ZIKV, dengue virus, and chikungunya virus; IgM enzyme-linked immunosorbent assays and plaque-reduction neutralization tests (PRNTs) were performed to detect ZIKV and dengue virus. No control neonates without microcephaly were evaluated. RESULTS: Among neonates, all 42 tested positive for ZIKV IgM: 38 of 42 serum specimens (90.5%) were positive, whereas 30 of 30 CSF specimens (100%) were positive. ZIKV IgM-specific ELISA ratios, calculated as the mean optical density (OD) of the test sample when reacted on viral antigen divided by the mean OD of the negative control when reacted with viral antigen, were higher in CSF specimens (median, 14.9 [range, 9.3-16.4]) than in serum (median, 8.9 [range, 2.1-20.6]; P = .0003). All ZIKV IgM-positive results among the neonates were confirmed by the detection of neutralizing antibodies. Mother/neonate pairs with primary ZIKV infection had neutralizing antibodies to ZIKV only, and mother/neonate pairs with ZIKV virus infection secondary to infection with another flavivirus had high titers of neutralizing antibodies to ZIKV. Among secondary infections, median titers in serum were 2072 (range, 232-12 980) for mothers and 2730 (range, 398-12 980) for neonates (P < .0001), and the median titer in CSF was 93 (range, 40-578) among neonates (P < .0001). CONCLUSIONS: Among neonates, detection of ZIKV IgM in serum is confirmatory of congenital ZIKV infection, and detection of ZIKV IgM in CSF is confirmatory of neurologic infection. Therefore, we recommend testing for ZIKV IgM in neonates suspected of having congenital ZIKV infection and performance of PRNTs in equivocal cases.
引用
- Cordeiro MT, Brito CA, Pena LJ, et al. Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV Antibodies in Neonates With Congenital Disease. J Infect Dis. 2016. PMID: 27923950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。